See also this year's filing and all EDGAR filings for this company.
PDF Report 0000872589_2022_Regeneron_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0000872589, Regeneron Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 14,014,900,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 11,419,900,000 |
| 4 | LiabilitiesCurrent | 3,932,500,000 |
| 5 | LiabilitiesNoncurrent | 2,733,500,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,817,527,899 |
| 9 | ResearchAndDevelopmentExpense | 2,937,684,990 |
| 10 | remainder_Expenses | 2,835,324,274 |
| 11 | remainder_Revenues | 53,790,240,702 |
| 12 | remainder_NetIncome | 421,374,369 |
| 13 | remainder_ComprehensiveNetIncome | -35,336,512 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 25,434,800,000 |
| 1 | Liabilities | 6,666,000,000 |
| 2 | Expenses | 7,590,537,163 |
| 3 | Revenues | 53,790,240,702 |
| 4 | StockholdersEquity | 18,768,800,000 |
| 5 | NetIncome | 46,621,077,908 |
| 6 | ComprehensiveNetIncome | 46,603,409,652 |
| 7 | BaseVar | 46,969,144,373 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 5.45 |
| 9 | EconomicCapitalRatio | 5.58 |
Edgar->Model Mapping
Feature Distribution
Change over Time
